You are here
- Home
- Drug Products
- All Drug Products
A Phase I, Open-label Study to Assess the Pharmacokinetics of Oral Fostamatinib in Healthy Japanese Subjects After Single and Multiple Doses
- Disease
- pharmacokinetics
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D4300C00032
- Study Id
- D4300C00032
- ClinicalTrials.gov ID
- NCT01608542
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
